Conformal radiotherapy for prostate cancer

References

• Hanks G E, Schultheiss T E, Hanlon A L, Hunt M, Lee W R, Epstein B E, et al. Dose escalation in the conformal treatment of prostate cancer: optimization is made possible by understanding the dose responses for control of cancer and late morbidity. Int J Radiat Oncol Biol Phys 1996; 36: 197
   Google Scholar
• Hanks G E, Hanlon A L, Schultheiss T E, Pinover W H, Movsas B, Epstein B E, et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization and future directions. Int J Radiat Oncol Biol Phys 1998; 41: 501–10
   PubMed Web of Science ®Google Scholar
• Hanks G E. Strategies for improving the outcome of patients with poor prognosis prostate cancer. Acta Oncol 1998; 37: 5–10
   PubMed Web of Science ®Google Scholar
• Zelefsky M, Leibel S, Gaudin P, Kutcher G, Fleshner N, Venkatramen E, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998; 41: 491–500
   PubMed Web of Science ®Google Scholar
• Hanks G E, Schultheiss T E, Hunt M A, Epstein B. Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1995; 31: 25–9
   PubMed Web of Science ®Google Scholar
• Zelefsky M J, Leibel S A, Kutcher G J, Kelson S, Ling C, Fuks Z. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. Cancer J Sci Am 1995; 1: 142–50
   Google Scholar
• Fukanaga-Johnson N, Sandler H M, McLaughlin W, Strawderman M S, Grijalva K H, Kish K E, et al. Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 1997; 38: 311–8
   PubMed Web of Science ®Google Scholar
• Sandler H M, Perez-Tamayo C, Ten Haken R K, Lichter A S. Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. Radiother Oncol 1992; 23: 53–4
   PubMed Web of Science ®Google Scholar
• Soffen E M, Hanks G E, Hwang C C, Chu J CH. Conformal static field therapy for low volume low grade prostate cancer with rigid immobilization. Int J Radiat Oncol Biol Phys 1991; 20: 141–6
   PubMed Web of Science ®Google Scholar
• Kagawa K, Lee W R, Schultheiss T E, Hunt M A, Shaer A H, Hanks G E. Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy. Int J Radiat Oncol Biol Phys 1997; 38: 319–25
   PubMedGoogle Scholar
• Roach M, Faillace-Akazawa P, Malfatti C, Holland J, Hricak H. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 1996; 35: 1011–8
   PubMed Web of Science ®Google Scholar
• McShan D L, Fraass B A, Lichter A S. Full integration of the beams eye view concept in computerized treatment planning. Int J Radiat Oncol Biol Phys 1990; 18: 1489–94
   Google Scholar
• Nishidai T, Nagata Y, Takahashi M, Ahe M, Yamaoka N, Ishihara K, et al. CT simulator: a new 3-D planning and simulating system for radiotherapy. Part 1: Description of system. Int J Radiat Oncol Biol Phys 1990; 18: 499–504
   PubMedGoogle Scholar
• Takahashi S. Conformation radiotherapy. Acta Radiol Suppl 1965; 1: 142
   Google Scholar
• Umegaki Y. Dose distribution in the moving field radiotherapy. Nippon Acta Radiol 1960; 20: 2191–209
   Google Scholar
• Michalski J, Purdy J, Winter K, Roach M, Vijayakumar S, Sandler H, et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys, (in press)
   Google Scholar
• Hanks G, Hanlon A, Pinover W, Horwitz E, Price R, Schultheiss T. Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys, (in press)
   Google Scholar
• Leibel S A, Heimann R, Kutcher G J, Zelefsky M J, Burman C B, Melain E, et al. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a Phase I dose-escalation study. Int J Radiat Oncol Biol Phys 1993; 28: 55–65
   Web of Science ®Google Scholar
• Ling C, Burman C, Chui C S, Jackson A, Kutcher C J, Leibel S, et al. Perspectives of multidimensional conformal radiation treatment. Radiother Oncol 1993; 29: 129–39
   PubMedGoogle Scholar
• Ling C C, Burman C, Chui C, Kutcher G J, Leibel S A, Lo Sasso T, et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys 1996; 35: 721–30
   PubMedGoogle Scholar
• Lo Sasso T, Chui C, Kutcher G, Leibel S, Fuks Z, Ling C. The use of a multi-leaf collimator for conformal radiotherapy of carcinomas of the prostate and nasopharynx. Int J Radiat Oncol Biol Phys 1993; 25: 161–70
   Google Scholar
• Mohan R, Mageras G, Baldwin B, Brewster L, Kutcher G, Leibel S, et al. Clinically relevant optimization of 3D conformal treatments. Med Phys 1992; 19: 933–44
   PubMed Web of Science ®Google Scholar
• Wurzer J, Nicolaou N, Hanlon A, Watkins-Bruner D, Hanks G. Long term durability of potency preservation in younger prostate cancer patients following 3D conformal radiation therapy (abstract). Int J Radiat Oncol Biol Phys 1999; 45(2 Suppl)169
   Google Scholar
• Pound C R, Partin A W, Epstein J I, Walsh P C. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Urol Clin North Am 1997; 24: 395–406
   PubMed Web of Science ®Google Scholar
• Hanlon A, Bruner D, Hanks G. Long term quality of life study in prostate cancer patients treated with three dimensional conformal radiation therapy: bowel and bladder quality of life symptoms are similar to that of the normal population (abstract). Int J Radiat Oncol Biol Phys 1999; 45(2 Suppl)240
   Google Scholar
• Hanks G. The case for external beam treatment of early stage prostate cancer. Urology, (in press)
   Google Scholar
• Shipley W, Thames H, Sandler H, Hanks G, Zietman A, Perez C, et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 1999; 281: 1558–604
   Google Scholar
• Pollack A, Zagars G. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys 1997; 39: 1011–8
   PubMed Web of Science ®Google Scholar
• Rasch C, Barilot I, Remeijer P, Touw A MVH, Lebesque J. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 1999; 43: 57–66
   PubMed Web of Science ®Google Scholar
• Milosevic M, Voruganti S, Blend R, Alasti H, Warde P, McLean M, et al. Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and urethrography. Radiother Oncol 1998; 47: 277–84
   PubMedGoogle Scholar
• Lattanzi J, McNeely S, Pinover W, Horwitz E, Das I, Price R, et al. A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. Int J Radiat Oncol Biol Phys 1999; 43: 719–25
   PubMed Web of Science ®Google Scholar
• Lattanzi J, McNeeley S, Hanlon A, Schultheiss T, Hanks G. Ultrasound-based stereotactic guidance of precision conformal external beam radiation therapy in clinically localized prostate cancer. Urology, (in press)
   Google Scholar